Reuters, the news and media division of Thomson Reuters, is the worlds largest multimedia news provider, reaching billions of people worldwide every day. The Alabama Legislature will determine the best uses of this funding. In addition to the funding for remediation, the state recovered approximately $40 million in attorneys fees and costs. I agree to be emailed to confirm my subscription to this list, HHS OCR Issues a Bulletin About Online Tracking Technologies and HIPAA, Twentieth Annual Pharmaceutical Compliance Congress Coming April 2023, Alabama Reaches $276 Million in Opioid-Related Settlements, announced that it reached $276 million in settlements. For Endo: Carole Rendon of BakerHostetler. Legal Reader is devoted to protecting consumers. Alabama will spend nearly one-third of the $9 million opioid crisis settlement money with McKinsey & Company, on investments in the state's forensic labs, according to the attorney general's office. Alabama Attorney General Steve Marshall reached a $276M settlement with Johnson & Johnson ( NYSE: JNJ ), McKesson ( NYSE: MCK) and Endo Pharmaceutical to resolve opioid related claims against. Alabama News Network Staff. State of Alabama Reaches Settlements with Two Opioid Manufacturers, One This week, Johnson & Johnson doled out $99 million to remove itself from | Alabama is set to get a $276 million payout from Johnson & Johnson, Endo and McKesson as part of an opioid litigation . Alabama Settles Opioid Claims With J&J, McKesson, Endo for $276 Related: Drug overdoses climbed in Alabama during pandemic, Opioid crisis roars back in Alabama as overdoses rise during pandemic, Opioid overdose deaths rise among Blacks; one Birmingham mother an inspiring model for recovery. In accordance with the Courts September 8, 2021 Order, the initial distribution of the net settlement fund took place on October 28, 2021. The state is one of eight that opted to not settle with McKesson, who along with rivals AmerisourceBergen and Cardinal Health agreed in July to pay $21 billion to resolve thousands of opioid lawsuits by other states and local governments. Endo Pharmaceutical: The State of Alabama and its subdivisions will receive $25 million in 2022 in a lump-sum payment.By comparison, two similarly populated states and their subdivisions settled . Defendants deny all allegations of wrongdoing or liability whatsoever. Reuters provides business, financial, national and international news to professionals via desktop terminals, the world's media organizations, industry events and directly to consumers. Washington, DC 20036, As the nonpartisan national forum for America's state and territory attorneys general and their staff, NAAG provides collaboration, insight, and expertise to empower and champion America's attorneys general. Information from the Attorney Generals Office, Tom Sizemore, 'Saving Private Ryan' actor, dies at 61, Montgomery Firefighters Investigating Large Church Fire Near Downtown, Tallassee Man, Woman Charged with Capital Murder in Death of Woman Found in Macon County, Lowndes County deputies searching for missing man, Spotty Showers Today; Severe Threat Friday Morning, Endo Pharmaceutical: The State of Alabama and its subdivisions will receive $25 million this year in a lump-sum payment. The Notice relates to a settlement of claims in asecurities class action brought by an Endo investor alleging, among other things, that Endo International plc and Endo Health Solutions Inc. (together, Endo) and certain of Endos former employees and officers (collectively, Defendants") violated the federal securities laws by making false and misleading statements and failing to disclose material adverse facts regarding the putative safety and abuse-deterrent properties of Reformulated Opana ER. Seattle, WA 98111-9411, SEB Investment Management AB v. Endo International plc, et al. The state of Alabama has settled with drugmaker Endo International Plc over its alleged role in the opioid epidemic and is now in talks with distributor McKesson Corp. 1850 M Street NW For McKesson: Harlan Prater of Lightfoot, Franklin & White and H. Lewis Gillis of Means Gillis Law. McKesson: The State of Alabama and its subdivisions will receive $141 million over nine years. The lawsuit claims that the drug companies and distributors used sophisticated and deceptive marketing to expand the use of opioids. The case is State of Alabama v. Endo Health Solutions Inc, et al, Montgomery County Circuit Court, Alabama, No. Sie knnen Ihre Einstellungen jederzeit ndern, indem Sie auf unseren Websites und Apps auf den Link Datenschutz-Dashboard klicken. Sara has been an invited speaker at a Careers in Publishing & Authorship event at Michigan State University and a Reading and Writing Instructor at Sylvan Learning Center. The company has said it is considering "strategic alternatives" if it cannot reach a global settlement, and plaintiffs have raised the possibility of Endo filing for bankruptcy. We are unapologetic in our dedication to informing the public and unafraid to call out those who are more focused on profits than peoples safety. The settlement, including the payment, will be subject to 100% participation by Louisiana's political subdivisions (to be provided to Endo by October 28, 2021) and the execution of definitive . The three companies will also pay a combined $40 million in attorneys fees. Browse an unrivalled portfolio of real-time and historical market data and insights from worldwide sources and experts. Due to the ongoing settlement talks and the deal negotiated with Endo, Democratic Judge J.R. Gaines set a new trial date for April 18, 2022. The share of each settlement that goes toward the state government will be deposited into the States General Fund and the Alabama legislature will work to determine the best use of that funding. If you have any questions regarding the distribution, please contact JND by calling 844-961-0316 or by sending an e-mail to Info@EndoSecuritiesLitigationSettlement.com. Endo Pharmaceutical: The State of Alabama and its subdivisions will receive $25 million this year in a lump-sum payment. I am grateful to each member of the Alabama Opioid Overdose and Addiction Council who has put in the time and energy to provide our legislators with a roadmap as they make critical decisions about the use of this money. Please enter your change or describe your request. Alabama reached a $276 million settlement agreement with Johnson & Johnson, McKesson and Endo Pharmaceutical for their role in the opioid epidemic, the state's attorney general announced on. She has an MBA degree with a concentration in Marketing and an MA in Clinical Mental Health Counseling, graduating with a 4.2/4.0 GPA. All rights reserved (About Us). Former Biden Staffers File New Trump Train Lawsuit Against San Marcos, Blog vs YouTube Over Other Websites: How to Choose, Behind the Story of Ghostbed vs. Purple Mattress Lawsuit, Investigation Reveals Goodyears Dunlop D402 Tires Have Caused Dozens of Motorcycle Accidents, Amputees Third Attempt at Holding Medical Personnel Responsible Pays Off. Alabama Reaches $276 Million in Opioid-Related Settlements Johnson & Johnson: The State of Alabama and its subdivisions will receive $70.3 million this year in a lump-sum payment. Wenn Sie Ihre Auswahl anpassen mchten, klicken Sie auf Datenschutzeinstellungen verwalten. They argue that the state cannot establish that they caused the opioid epidemic and that Alabama public nuisance law does not apply to a harm caused by a product, rather than an interference with public property. Save my name, email, and website in this browser for the next time I comment. Alabama settles opioid claims against Endo, in talks with McKesson, McKesson, Endo face multi-billion dollar opioid trial in Alabama. v. Endo International (Lidoderm) complaint 07-19-19 Alabama et al. Court-appointed Lead Plaintiff SEB Investment Management AB, on behalf of itself and the Settlement Class, reached a settlement of the Action withDefendants for $82,500,000 in cash ("Settlement"). See here for a complete list of exchanges and delays. Alabama settles opioid claims against Endo, in talks with McKesson Johnson & Johnson also notated that the settlement is not an admission of any wrongdoing and that the company no longer distributes its prescription opioids, and that its drugs accounted for less than 1% of total opioid prescriptions in both Alabama and the United States. By comparison, two similarly populated states and their subdivisions settled with Endo for 26% and 35% of the total that Alabama was able to secure. New Hampshire agreed to the settlement with the distributors but not the one with Johnson & Johnson. Access unmatched financial data, news and content in a highly-customised workflow experience on desktop, web and mobile. "As the court knows, the state has completed a settlement with Endo, the other defendant," McKesson said. All three companies have denied any wrongdoing. Weathersby, et al. While the state has not said in public filings how much it is seeking, McKesson in an August filing pegged the amount at up to $20 billion, which would dwarf any recovery in an opioid lawsuit so far. The breakdown of the settlements are as follows: Endo Pharmaceutical: The State of Alabama and its subdivisions will receive $25 million this year in a lump-sum payment. McKesson, Endo face multi-billion dollar opioid trial in Alabama We envisioned and developed a State plan long before there was any funding to make it a reality, and I am pleased that we can finally put our plan to good use.. Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement, Privacy Policy and Cookie Statement, and Your Privacy Choices and Rights (each updated 1/26/2023). The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Advance Local. Under the national deals, Alabama would've received significantly less from Endo, the office said. Alabama will receive $7.6 million this year, and a total of $9 million, from McKinsey & Company. The Attorney General's Office does not handle any domestic cases (example: child support, child custody, divorce, etc.) In an August summary judgment motion, McKesson also argued the state lacked evidence the drugs it distributed were diverted and said the rise in opioid shipments was due not to its actions but doctors writing more prescriptions. CV-2019-901174. If you have an ad-blocker enabled you may be blocked from proceeding. Terms of the settlement were not immediately available. Certain persons and entities are excluded from the Settlement Class by definition (see 20 of the Notice). As part of their settlement, Johnson & Johnson will pay $70.3 . The states alleged that Endo filed patent infringement suits against Watson after Watson sought FDA approval of a generic version of Lidoderm. P.O. Eighteen states reached a settlement with Endo Pharmaceuticals Inc. under which Endo paid $2.3 million to settle allegations it entered into a reverse-payment agreement to obstruct generic competition to Lidoderm, a pain relief patch frequently used to treat shingles. See here for a complete list of exchanges and delays. By comparison, two similarly populated states and their subdivisions settled with Endo for 26% and 35% of the total that Alabama was able to secure.